STOCK TITAN

CACI (NYSE: CACI) director converts 84 RSUs, holds 2,237 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

CACI International director Philip O. Nolan exercised restricted stock units into common shares as part of his equity compensation. On April 14, 2026, 84 RSUs converted into 84 shares of CACI common stock at a stated price of $0.00 per share, a non-cash equity award.

Following the transaction, Nolan directly held 2,237 CACI common shares and 170 restricted stock units. The footnote explains these RSUs come from a grant of 338 RSUs on October 17, 2025, vesting in four scheduled tranches through October 2026, indicating this is a routine, pre-set vesting event rather than an open-market trade.

Positive

  • None.

Negative

  • None.
Insider Nolan Philip O
Role Director
Type Security Shares Price Value
Exercise Restricted Stock Units 84 $0.00 --
Exercise CACI Common Stock 84 $0.00 --
Holdings After Transaction: Restricted Stock Units — 170 shares (Direct); CACI Common Stock — 2,237 shares (Direct)
Footnotes (1)
  1. [object Object]
RSUs Exercised 84 units Restricted Stock Units converted on April 14, 2026
Shares Acquired 84 shares CACI common stock received from RSU conversion
Shares Held After 2,237 shares Direct CACI common stock holdings post-transaction
RSUs Remaining 170 units Restricted stock units outstanding after April 14, 2026 vesting
Original RSU Grant 338 units RSUs granted on October 17, 2025 per footnote
Restricted Stock Units financial
"was granted 338 Restricted Stock Units (RSUs) that will vest"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Form 4 regulatory
"INSIDER FILING DATA (Form 4): {"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
vesting schedule financial
"will vest according to the following vesting schedule: 84 shares will vest"
A vesting schedule is a timeline that determines when someone gains full ownership of certain benefits, such as company stock or retirement contributions. Think of it like earning the right to own a gift gradually over time, rather than receiving it all at once. It matters to investors because it affects when they can fully access or sell these benefits, influencing their financial planning and decision-making.
CACI Common Stock financial
"underlying_security_title": "CACI Common Stock""
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Nolan Philip O

(Last)(First)(Middle)
12021 SUNSET HILLS ROAD

(Street)
RESTON VIRGINIA 20190

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
CACI INTERNATIONAL INC /DE/ [ CACI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/14/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
CACI Common Stock04/14/2026M84A(1)2,237D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(1)04/14/2026M84 (1) (1)CACI Common Stock84(1)170D
Explanation of Responses:
1. On October 17, 2025, Philip O. Nolan, was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026.
Remarks:
Philip O. Nolan04/16/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did CACI (CACI) director Philip O. Nolan report?

Philip O. Nolan reported exercising 84 restricted stock units into 84 shares of CACI common stock. The exercise occurred on April 14, 2026 at a stated price of $0.00 per share, reflecting routine equity compensation rather than an open-market stock purchase.

How many CACI (CACI) shares does Philip O. Nolan hold after this Form 4?

After the reported transactions, Philip O. Nolan directly holds 2,237 shares of CACI common stock. He also holds 170 restricted stock units, which represent additional shares scheduled to vest under a previously granted equity award, according to the disclosed vesting schedule.

What is the origin of the restricted stock units in this CACI (CACI) filing?

The restricted stock units come from a grant of 338 RSUs awarded to Philip O. Nolan on October 17, 2025. The grant vests in four tranches: 84 shares on January 14, 2026, 84 on April 14, 2026, 85 on July 13, 2026, and 85 on October 11, 2026.

Was the CACI (CACI) insider transaction an open-market buy or sell?

No, the transaction was not an open-market buy or sell. It was coded as an “M” transaction, meaning an exercise or conversion of a derivative security, where restricted stock units vested and converted into common shares as part of Nolan’s equity compensation package.

How many restricted stock units did Philip O. Nolan exercise in this CACI (CACI) report?

He exercised 84 restricted stock units, which converted into 84 shares of CACI common stock. This exercise aligns with the scheduled vesting of his October 17, 2025 RSU grant, specifically the tranche vesting on April 14, 2026 under the disclosed vesting schedule.

Does this CACI (CACI) Form 4 show remaining unvested restricted stock units for Nolan?

Yes. After exercising 84 RSUs, Nolan has 170 restricted stock units remaining. These RSUs are tied to the October 17, 2025 grant and are scheduled to vest in two further tranches on July 13, 2026 and October 11, 2026, based on the footnote disclosure.